Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | HLA-DOB | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
mRNA | SEC14L4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
mRNA | CDRT15L2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
mRNA | DBH | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | CTHRC1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
mRNA | UNC13C | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | INO80B-WBP1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | TAL1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | METRNL | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |